Results 21 to 30 of about 571,237 (168)

Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency

open access: yesJournal of the Peripheral Nervous System, 2023
AbstractRiboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised by pontobulbar palsy, sensorineural deafness, sensory ataxia, muscle weakness, optic atrophy and respiratory failure. Riboflavin supplementation is beneficial in short‐term reports, but the quantum of benefit in various clinical ...
Kayla Cornett   +2 more
exaly   +3 more sources

Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations. [PDF]

open access: yesDev Med Child Neurol
https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16083
Fennessy JR   +5 more
europepmc   +5 more sources

Successful treatment of a genetic childhood ataxia due to riboflavin transporter deficiency. [PDF]

open access: yesCerebellum Ataxias, 2018
Riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome) is a rare recessive neurodegenerative disorder that can present with gait ataxia, primarily due to sensory neuropathy as well as cerebellar involvement. Although sensorineural hearing loss, bulbar palsy, and optic atrophy are typical, presentation may be variable and an atypical ...
Fan J, Fogel BL.
europepmc   +4 more sources

Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies [PDF]

open access: yesFrontiers in Neurology
BackgroundRiboflavin (vitamin B2), a precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), is essential for mitochondrial function, redox balance, and neuronal viability.
Zhiming Tao   +11 more
doaj   +2 more sources

Oral therapy for riboflavin transporter deficiency - What is the regimen of choice? [PDF]

open access: yesParkinsonism and Related Disorders, 2019
Contains fulltext : 206709.pdf (Publisher’s version ) (Open Access)
Emil Ygland Rödström   +1 more
exaly   +3 more sources

Case Report: SLC52A2 variants cause Brown-Vialetto-Van Laere syndrome type 2, characterized by pure red cell aplastic anemia: clinical and genetic features of three Chinese children [PDF]

open access: yesFrontiers in Pediatrics
ObjectiveTo report three Chinese pediatric cases of Brown-Vialetto-Van Laere syndrome type 2 (BVVLS2) presenting with pure red cell aplasia (PRCA) as the core manifestation, and to analyze their clinical features, molecular basis, and response to ...
Zhenzhen Chen   +11 more
doaj   +2 more sources

Development of a functional outcome measure for riboflavin transporter deficiency

open access: yesJournal of the Peripheral Nervous System
AbstractBackground and AimsRiboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised clinically by pontobulbar palsy, sensory ataxia, sensorineural deafness, muscle weakness, optic atrophy and respiratory failure.
Marnee J McKay   +2 more
exaly   +3 more sources

Riboflavin Transporter 1 Deficiency Caused by a Homozygous Single Exonal Deletion of [PDF]

open access: yesAnnals of Child Neurology, 2020
Urim Kang   +4 more
doaj   +4 more sources

C. elegans model of riboflavin transporter deficiency (RTD) disorder reveals deficits in synaptic transmission and movement [PDF]

open access: yesGenes and Diseases
Ramesh K. Narayanan   +6 more
doaj   +2 more sources

Brown Vialetto Van Laere syndrome: presenting with left ventricular non-compaction and mimicking mitochondrial disorders

open access: yesThe Turkish Journal of Pediatrics, 2021
Background. Brown-Vialetto-Van Laere syndrome (BVVLS) is a rare, treatable neurodegenerative disorder with a variable clinical presentation, caused by mutations in three different riboflavin transporter genes. Case.
Berna Şeker Yılmaz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy